文献速递眼底病与葡萄膜炎

黄斑深层毛细血管丛缺血作为识别需转诊糖尿病视网膜病变的生物标志物

Macular Deep Capillary Plexus Ischemia as a Biomarker for Identifying Referable Diabetic Retinopathy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

该横断面研究分析193例糖尿病患者290只眼,评估3×3-mm黄斑OCTA测量的深层毛细血管丛缺血指标识别需转诊糖尿病视网膜病变(refDR)的能力。深层毛细血管丛几何灌注缺损(GPD-DCP)单独判别AUC为0.913,联合临床因素后AUC从0.865升至0.934(ΔAUC=+0.070,P=0.002)。作者认为GPD-DCP判别力优良且校准良好,支持其用于筛查和风险评估。

要点

  • GPD-DCP单独识别refDR的AUC为0.913(95%CI 0.879-0.947)。
  • GPD-DCP联合临床因素使AUC从0.865升至0.934(ΔAUC=+0.070,P=0.002)。
  • 临床相关阈值下GPD-DCP达95%灵敏度伴63.5%特异度,或95%特异度伴63.2%灵敏度。

核心结论

  • GPD-DCP对refDR具有优良且校准良好的判别力,联合标准临床因素可显著改善风险分层,支持其用于筛查和风险评估。

研究设计与样本

  • 横断面研究,纳入193例糖尿病患者的290只眼,糖尿病严重程度不一但无黄斑水肿。
  • 对黄斑OCTA平均图像进行处理计算多种OCTA指标(包括几何灌注缺损GPD),用OCTA-only广义估计方程逻辑模型及联合临床协变量(年龄、性别、糖尿病病程、糖化血红蛋白、高血压)的模型评估各指标判别refDR的能力。
  • 以曲线下面积(AUC)量化准确性,用1000次聚类自助重采样评估模型间差异(ΔAUC),并用受试者层面五折交叉验证和Brier评分评估最佳OCTA-only模型的内部效度和校准。

主要发现

  • 10项OCTA指标中,深层毛细血管丛几何灌注缺损(GPD-DCP)单独判别力最高,AUC=0.913(95%CI 0.879-0.947)。
  • GPD-DCP联合临床协变量模型较仅临床协变量模型AUC从0.865升至0.934(ΔAUC=+0.070,P=0.002)。
  • 临床相关阈值下,GPD-DCP达95%灵敏度伴63.5%特异度,以及95%特异度伴63.2%灵敏度。
  • 受试者层面交叉验证显示性能稳健(平均[SD] AUC=0.919[0.034]),校准优良(Brier评分=0.115)。

关键数值与推荐

  • GPD-DCP单独判别refDR的AUC=0.913(95%CI 0.879-0.947)。
  • 联合临床协变量模型AUC=0.934,较仅临床协变量模型AUC=0.865提高ΔAUC=+0.070(P=0.002)。
  • GPD-DCP在95%灵敏度时特异度为63.5%,在95%特异度时灵敏度为63.2%。
  • 交叉验证平均(SD)AUC=0.919(0.034),Brier评分=0.115。

临床怎么用

  • 作者认为GPD-DCP可用于筛查和风险评估,联合标准临床因素可改善风险分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate deep capillary plexus (DCP) ischemia measured on 3 × 3-mm macular optical coherence tomography angiography (OCTA) as a biomarker for referable diabetic retinopathy (refDR). METHODS: In this cross-sectional study, we analyzed 290 eyes from 193 patients with diabetes and varying severity but without macular edema. Averaged macular OCTA images were processed to calculate a range of OCTA metrics, including geometric perfusion deficits (GPDs). Each OCTA metric was evaluated for its ability to discriminate refDR using (1) an OCTA-only generalized estimating equation logistic model and (2) a model combining the metric with clinical covariates (age, sex, diabetes duration, hemoglobin A1c, and hypertension). Accuracy was quantified by the area under the curve (AUC), and model-to-model differences (ΔAUC) were evaluated using 1000-iteration cluster-bootstrap resampling. Internal validity and calibration of the best-performing OCTA-only model were assessed using subject-wise fivefold cross-validation and the Brier score. RESULTS: Among 10 OCTA metrics, GPDs in the DCP (GPD-DCP) achieved the highest standalone discrimination (AUC = 0.913; 95% confidence interval, 0.879-0.947) and significantly improved the model with clinical covariates (AUC increase from 0.865 to 0.934; ΔAUC = +0.070; P = 0.002). At clinically relevant thresholds, GPD-DCP achieved 95% sensitivity with 63.5% specificity, as well as 95% specificity with 63.2% sensitivity. Subject-wise cross-validation confirmed robust performance (mean [SD] AUC = 0.919 [0.034]), with excellent calibration (Brier score = 0.115). CONCLUSIONS: GPD-DCP offers excellent, well-calibrated discrimination of refDR and significantly improves risk stratification when combined with standard clinical factors, supporting its use for screening and risk assessment.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Kakihara S, Zhuang K, Fawzi AA, et al. Macular Deep Capillary Plexus Ischemia as a Biomarker for Identifying Referable Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2025. PMID: 41251524. doi:10.1167/iovs.66.14.45

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。